Literature DB >> 7525083

The acute phase response: general aspects.

I Kushner1, D L Rzewnicki.   

Abstract

The acute phase response in a given individual represents the integrated sum of multiple, separately regulated changes. Although many of these changes commonly occur together in affected individuals, clinical experience indicates that not all of them occur in all individuals, indicating that they must be individually regulated. For example, febrile patients may have normal blood levels of CRP and vice versa, leukocytosis does not always accompany other acute phase phenomena, and many instances of discordance between levels of the various acute phase proteins are seen. Cytokines function as part of a complex regulatory network, a signalling language in which information is conveyed to cells by combinations, and perhaps sequence, of intercellular messenger molecules. The effects of combinations of cytokines are complex. To use a somewhat crude simile, individual cytokines can be thought of as words which bear informational content and which may, on occasion, communicate a complete message. More commonly, however, the actual messages received by cells probably resemble sentences, in which combinations and sequences of words convey information. Currently available data suggest that hepatocytes receive a complex mixture of humoral or paracrine signals during the acute phase response. These are integrated by multiple interacting signal transducing mechanisms to cause finely regulated changes in plasma protein synthesis. Regulation largely occurs by transcriptional control, but post-transcriptional mechanisms, including translational regulation, may also participate. Both the extracellular and intracellular mechanisms that mediate the response of the hepatocyte to inflammatory stimuli appear to be highly complex and involve multiple overlapping, concurrent and parallel pathways. Enough is known at present to conclude that IL-6 is a major participant in these plasma protein changes. Regulation of non-hepatocyte acute phase phenomena has not been delineated as thoroughly, but clearly involves a number of inflammation-associated cytokines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525083     DOI: 10.1016/s0950-3579(05)80113-x

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  20 in total

1.  Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.

Authors:  S J Semple; L L Smith; A J McKune; J Hoyos; B Mokgethwa; A F San Juan; A Lucia; A A Wadee
Journal:  Br J Sports Med       Date:  2006-02       Impact factor: 13.800

2.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

Review 3.  Anti-amyloid drugs: potential in the treatment of diseases associated with aging.

Authors:  R Kisilevsky
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

4.  Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Authors:  Vivaswath S Ayyar; Richard R Almon; Debra C DuBois; Siddharth Sukumaran; Jun Qu; William J Jusko
Journal:  J Proteomics       Date:  2017-03-14       Impact factor: 4.044

5.  The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.

Authors:  Xin Wang; Francesca Cattaneo; Lisa Ryno; John Hulleman; Natàlia Reixach; Joel N Buxbaum
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

6.  Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone.

Authors:  Iain A Murray; Colin A Flaveny; Christopher R Chiaro; Arun K Sharma; Rachel S Tanos; Jennifer C Schroeder; Shantu G Amin; William H Bisson; Siva K Kolluri; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2010-12-02       Impact factor: 4.436

7.  The acute phase response and exercise: court and field sports.

Authors:  K E Fallon; S K Fallon; T Boston
Journal:  Br J Sports Med       Date:  2001-06       Impact factor: 13.800

Review 8.  Analytic review: Interleukin-6 in surgery, trauma, and critical care: part I: basic science.

Authors:  Randeep S Jawa; Sergio Anillo; Kristin Huntoon; Heinz Baumann; Mahmoud Kulaylat
Journal:  J Intensive Care Med       Date:  2011 Jan-Feb       Impact factor: 3.510

9.  Stress response to hepatectomy in patients with a healthy or a diseased liver.

Authors:  Albert Kuo-Mao Lan; Hsiang-Ning Luk; Shigeru Goto; Shyr-Ming Sheen Chen; Hock-Liew Eng; Yaw-Sen Chen; Vanessa H de Villa; Chih Chi Wang; Yu-Fen Cheng; Chao-Long Chen; Ju-Hao Lee; Bruno Jawan
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

10.  Innate immune responses of calves during transient infection with a noncytopathic strain of bovine viral diarrhea virus.

Authors:  Doris Müller-Doblies; Adrian Arquint; Patrick Schaller; Peter M H Heegaard; Monika Hilbe; Sarah Albini; Carlos Abril; Kurt Tobler; Felix Ehrensperger; Ernst Peterhans; Mathias Ackermann; Alfred Metzler
Journal:  Clin Diagn Lab Immunol       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.